Wave Life Sciences Ltd — Quarterly Cash Flow (NASDAQ:WVE) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics

Quarterly Annual

Total assets 352.21 M288.34 M252.35 M241.38 M638.5 M Total liabilities 134.82 M108.67 M105.22 M108.95 M112.27 M Total equity 209.51 M171.8 M139.27 M124.55 M518.36 M Total liabilities & shareholders' equities 352.21 M288.34 M252.35 M241.38 M638.5 M Total debt ————— Net debt —————

Haberler

Wave Life Sciences ABD’ye taşınmayı planlıyor

Wave Life Sciences (WVE) Surges 9.5%: Is This an Indication of Further Gains?

Wave Life Sciences Ltd. (WVE) Discusses Positive Interim Phase I Data from INLIGHT Trial of WVE-007 for Obesity Transcript

WVE Posts Interim Data From Phase I Study on WVE-007, Stock Tanks

Wedbush, deneme verileri sonrası Wave Life Sciences hisse hedefini düşürdü

RBC Capital, Wave Life Sciences hissesi için görüşünü korudu

Wave Life Sciences Ltd. (WVE) Discusses Positive Interim Phase I Data from INLIGHT Trial of WVE-007 for Obesity - Slideshow (NASDAQ:WVE) 2026-03-26

Clear Street, obezite pazar görünümü nedeniyle Wave Life Sciences hisse hedefini düşürdü

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.01%

Leerink, rakip verilerine rağmen iBio için Outperform görüşünü korudu

Leerink obezite ilacı verisi sonrası Wave Life Sciences hisse hedefini düşürdü

Jefferies, obezite verileri sonrası WAVE Life Sciences’ın hedefini 18 dolara düşürdü